HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/4/R1069    most recent 00753.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Woods, L. L. Search for Related Content PubMed PubMed Citation Articles by Woods, L. L.

DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY

Maternal glucocorticoids and prenatal programming of hypertension

Division of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon

Submitted 24 October 2005 ; accepted in final form 14 April 2006

Maternal glucocorticoids have been postulated to play an important role in prenatal programming for adult hypertension in the offspring. However, we have shown previously that offspring hypertension caused by maternal dexamethasone subcutaneous administration at 100 µg·kg^–1·day^–1 can be accounted for by the corresponding reduction in food intake that these mothers experience. The present studies were designed to determine whether there is a lower dose of dexamethasone that does not reduce maternal food intake yet still causes hypertension in the adult offspring. Pregnant rats were treated with subcutaneous dexamethasone at 50 (D50) or 25 (D25) µg·kg^–1·day^–1 on days 15–20 of pregnancy. An additional group was untreated or received vehicle injections (control). D25 and D50 dams reduced their food intake by 17% during and after treatment and gained 31% less weight than control over the course of gestation. In adulthood (21 wk), chronically instrumented male offspring of D50 and D25 had normal blood pressures (D50: 131 ± 2 mmHg and D25: 127 ± 3 mmHg vs. 127 ± 2 mmHg in control). Qualitatively similar results were found in female offspring. Thus neither dexamethasone per se at these doses nor the accompanying modest reductions in maternal food intake and weight gain have blood pressure programming effects. As far as has been tested, there does not appear to be a dose of dexamethasone that, given over this time period in the rat, programs offspring hypertension without reducing maternal food intake and weight gain. These data do not support the hypothesis that maternal glucocorticoids program offspring hypertension directly.

prenatal dexamethasone; glomerular filtration rate; rat

This article has been cited by other articles:

				K. A. Brennan, S. Kaufman, S. W. Reynolds, B. T. McCook, G. Kan, I. Christiaens, M. E. Symonds, and D. M. Olson Differential effects of maternal nutrient restriction through pregnancy on kidney development and later blood pressure control in the resulting offspring Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R197 - R205. [Abstract] [Full Text] [PDF]

				A. G. Bechtold, K. Vernon, T. Hines, and D. A. Scheuer Genetic predisposition to hypertension sensitizes borderline hypertensive rats to the hypertensive effects of prenatal glucocorticoid exposure J. Physiol., January 15, 2008; 586(2): 673 - 684. [Abstract] [Full Text] [PDF]

				C. A. Crowther, L. W. Doyle, R. R. Haslam, J. E. Hiller, J. E. Harding, J. S. Robinson, and the ACTORDS Study Group Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids N. Engl. J. Med., September 20, 2007; 357(12): 1179 - 1189. [Abstract] [Full Text] [PDF]